A thorough review on ovarian cancer, treatment guidelines and emerging therapies available for the disease. The book was originally commissioned due to recent developments in therapies for ovarian cancer. This concise pocket book will review ovarian cancers epidemiology, clinical features, diagnosis and medical management. Busy healthcare professionals will benefit from this text, which will not only cover the foundation of ovarian cancer management, but discuss up-to-date national and international treatment guidelines and upcoming therapies.Treatment Guidelines.- Emerging Therapies.- Epidemiology.- Clinical Features.- Diagnosis.- Medical management.
From the book reviews:
The focus of this book is on high-yield topics in ovarian cancer, ranging from screening and diagnosis to treatment options and landmark articles. & The audience includes all those who help care for patients with ovarian cancer, including medical students, obstetrics/gynecology residents, oncology fellows, oncology nurses, or board certified gynecologic oncologists or medical oncologists. & This is an excellent handbook that certainly will be useful to anyone involved with the care of ovarian cancer patients. (Lindsay Midori Kuroki, Doodys Book Reviews, March, 2015)
Krishnansu S Tewari, MD, is a Professor and Director of Research in the Division of gynecologic oncology at the University of California (UC) Irvine. He received his bachelors degree in molecular biology at UC Berkeley, and went to medical school, completed his residency in obstetrics and gynecology, and fellowship in gynecologic oncology at the UC Irvine. He serves as the Principal Investigator of the National Cancer Institutes NRGOncology Cooperative Group and Gynecologic Oncology Group Partners at UC Irvine. At UC Irvine, Dr Tewari is the Chairman of the Clinical Trials Protocol Review and Monitoring Committee and the Director of the Women's Disease Oriented Team lc,